Cell Point India Ltd (CELLPOINT) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Cell Point India Ltd on NSE and BSE, with an AI summary of each filing.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 10 Nov 2026, 5:30 am
Cell Point (India) Schedules Board Meeting for H1 FY27 Results Cell Point (India) Limited has scheduled a Board of Directors meeting on 10th Nov'26 to consider and approve the unaudited financial results for the half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the company's trading window has been closed since 1st Oct'26 and will reopen 48 hours following the approval and disclosure of the financial results.
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 10 Nov 2026, 5:30 am
Cell Point (India) Board to Review Half-Year Results on 10th Nov'26 Cell Point (India) Limited has scheduled a Board of Directors meeting on 10th Nov'26 to inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
Structural Digital Database for Q2 FY 2026-27
Others (Uncategorized) · 14 Oct 2026, 6:31 pm
Cell Point (India) Submits SDD Compliance Certificate for Quarter Ended Sep'26 Cell Point (India) Limited submitted its Structured Digital Database compliance certificate for the quarter ended 30th Sep'26, pursuant to SEBI Prohibition of Insider Trading Regulations. Practising Company Secretary B. Umamaheswara Rao certified that the company maintains an internal, non-tamperable SDD with access controls, audit trails, and eight-year record retention capabilities. No events requiring Unpublished Price Sensitive Information disclosure occurred during the quarter, no non-compliances were observed, and no remedial actions were required.
Cell Point (India) Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026-27
Others (Uncategorized) · 10 Oct 2026, 6:38 pm
Cell Point (India) Reports Corporate Governance Exemption for Q2 FY27 Cell Point (India) Limited informed the NSE on 10th Oct'26 regarding the non-applicability of SEBI (LODR) Regulations, 2015 corporate governance provisions (Regulations 17 to 27) for the quarter ended 30th Sep'26. Under Regulation 15, the company is exempt from mandatory corporate governance compliance because its securities are listed on the SME Exchange. The company confirmed that it continues to adhere to corporate governance best practices despite the regulatory exemption.
Cell Point (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 01 Oct 2026, 6:12 pm
Cell Point (India) Limited has informed the Exchange regarding Proceedings of 13th Annual General Meeting held on September 29, 2026
Annual General Meeting · 29 Sept 2026, 7:37 pm
Cell Point (India) Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "NEWSPAPER ADVERTISEMENT FOR 13th ANNUAL GENERAT MEETING,RECORD DATE AND E-VOTING INFORMATION -CELLPOINT-REG".
Annual General Meeting · 11 Sept 2026, 10:08 pm
Cell Point (India) Limited has informed the Exchange about CORRIGENDUM TO ANNUAL REPORT 2026
Annual Report · 09 Sept 2026, 10:50 pm
Cell Point (India) Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meeting to be held on September 29, 2026
Annual General Meeting · 08 Sept 2026, 6:24 pm
Cell Point (India) Limited has informed the Exchange regarding 'Scrutinizer Appointment'. for E-voting/Physical Voting at 13th AGM
Annual General Meeting · 03 Sept 2026, 6:42 pm
Cell Point (India) Limited has informed the Exchange regarding Notice of 13th Annual General Meeting to be held on September 29, 2026
Annual General Meeting · 03 Sept 2026, 5:52 pm
Cell Point (India) Limited has informed the Exchange about reappointment of MD and WTD
Others (Uncategorized) · 02 Sept 2026, 10:58 pm
Cell Point India Re-appoints Key Management for Five-Year Term Beginning 2027 Cell Point (India) Ltd's Board approved the re-appointment of Mr. Mohan Prasad Panday as Managing Director and Mr. Bala Balaji Panday as Whole Time Director. Both re-appointments span a five-year term effective 1st Apr'27 to 31st Mar'32, subject to shareholder approval. The appointees, who are brothers with over 20 years of experience, will continue to lead company operations. The company confirmed neither director is debarred from holding office by SEBI.
Cell Point (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.
Outcome · 02 Sept 2026, 10:53 pm
Cell Point Sets AGM Date and Approves Key Board Re-appointments Cell Point (India) Limited scheduled its 13th AGM for 29th Sep'26 and set 22nd Sep'26 as the eligibility date for e-voting. Key agenda items for shareholder approval include re-appointing Mr. Mohan Prasad Panday as Managing Director and Mr. Bala Balaji Panday as Whole-Time Director for a five-year term. The board also approved the re-appointment of Mrs. Kiranmai Panday as Non-Executive Director and adopted the FY26 Secretarial and Board Reports. Big Share Services Private Limited was appointed as the e-voting agency for the period spanning 26th to 28th Sep'26.
To consider and approve the Draft Report from Board of directors for the financial year ended on March 31, 2026 and others
Intimation · 24 Aug 2026, 11:14 pm
Cell Point Board Meeting to Approve FY26 Results, Reappoint Key Directors Cell Point (India) Limited has scheduled a board meeting for 02 Sep'26 to approve its draft director's report and secretarial audit report for the financial year ending 31 Mar'26. The agenda includes setting the date and record date for the 13th AGM. Key proposals involve the reappointments of Mohan Prasad Panday as Managing Director and Bala Balaji Panday as Whole Time Director, each for a five-year term effective 01 Apr'27, subject to shareholder approval. The reappointment of Kiranmai Panday will also be considered.
CELL POINT (INDIA) Limited has informed the Exchange about Board Meeting to be held on 02-Sep-2026 to consider Other business.
Intimation · 24 Aug 2026, 11:12 pm
Cell Point (India) Ltd. Schedules Board Meeting Cell Point (India) Ltd. has announced a Board of Directors meeting scheduled for 02-Sep'26. The agenda is to consider unspecified "Other business."
Cell Point (India) Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q1 FY 2026-27
Others (Uncategorized) · 14 Jul 2026, 6:12 pm
Cell Point (India) Exempt from Corporate Governance Norms for Q1 FY27 Cell Point (India) Limited (NSE: CELLPOINT) has informed the exchange on 14th Jul'26 that Corporate Governance provisions under SEBI (LODR) Regulations, 2015 are not applicable for the quarter ended 30th Jun'26. The exemption is claimed under Regulation 15, which applies to companies with a net worth not exceeding Rs. 25 Crore or those listed on the SME Exchange. The company confirmed it is listed on the SME Exchange, thereby qualifying for the non-applicability of these specific compliance requirements.
Structural Digital Database for the Q1 of FY26-27
Others (Uncategorized) · 14 Jul 2026, 6:04 pm
Cell Point Submits Insider Trading Compliance Certificate for YE Jun'26 Cell Point (India) Limited filed its Structured Digital Database (SDD) compliance certificate for the year ended 30th Jun'26, as per SEBI's Insider Trading Regulations. The company confirmed it has a non-tamperable SDD with controlled access and an audit trail maintained for 8 years. It also stated that while it was required to capture one event during the year, it had captured two events in its database. The certificate was filed with the NSE on 14th Jul'26.
The Exchange had sought clarification from Cell Point (India) Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Financial Result · 10 Jul 2026, 6:08 pm
Cell Point India Ltd - Financial Result for the Quarter ended 30th Sep'25 (Standalone, INR Lakh) ■ Revenue: 17,695 (+15.3% YoY | +3.4% QoQ) ■ EBITDA: 422 (-8.5% YoY | +56.0% QoQ) ■ EBITDA Margin (%): 2.4 (-62 bps YoY | +80 bps QoQ) ■ PBT: 26.6 (-16.3% YoY | +77.4% QoQ) ■ PAT: 19.1 (-14.8% YoY | -90.6% QoQ) ■ EPS (INR): 0.10 (-15.0% YoY | -90.6% QoQ)
Cell Point (India) Limited has informed the Exchange about Appointment of Mr Ponnada Gopala Ranga as Chief Financial Officer of the company w.e.f. Jun 27, 2026.
Change in Management · 27 Jun 2026, 9:34 pm
Cell Point (India) Appoints New Chief Financial Officer Cell Point (India) Ltd. has appointed Mr. Ponnada Gopala Ranga as its new Chief Financial Officer (CFO) and Key Managerial Personnel, effective Jun 27, '26. Mr. Ranga is a qualified Chartered Accountant with over 29 years of experience, including a prior role at NTPC. His expertise covers financial management and reporting, accounting, treasury, taxation, budgeting, and internal controls. The appointment follows the recommendation of the company's Nomination and Remuneration Committee and was approved by the Board of Directors.